Weight management research hub

A research study of a new medicine (NNC0650-0013) in healthy men

This study is looking for healthy men to test a new medicine for the first time. The medicine might help with weight and type 2 diabetes. It's an early-stage study to see how safe it is and how it works in the body.

Fentanyl effect on ventilatory pattern under sham postsurgical conditions – an exploratory study in healthy men and women – the FAME study

This study, called FAME, is looking at how a pain medicine called fentanyl affects breathing in healthy adults. Researchers want to understand its effects better to improve safety, especially after operations. It's a key step in understanding how this medicine works.

A Single Dose, Fed state, Crossover Replicate, Bioequivalence Study of Naproxen 500 mg/ Esomeprazole 20 mg modified-release tablets (Antibiotice S.A.) versus Vimovo® 500 mg/20 mg film coated tablets (Grunenthal GmbH)

This study compares a new naproxen and esomeprazole tablet to an existing one called Vimovo. We want to see if the new tablet works in the body the same way as Vimovo. This helps ensure new medicines are just as effective.

A Single Dose, Two – stage, Fasting State, Bioequivalence Study of Rifaximin 200 mg, film-coated tablets (Antibiotice S.A.) vs. Normix® 200 mg, film-coated tablets (Alfasigma S.p.A)

This study is testing if a new version of the antibiotic rifaximin (200mg tablets) works in the same way as the original, approved version. We are looking for healthy adults to take part. It helps ensure new medicines are just as effective and safe as current ones.

A study to assess the safety, tolerability and pharmacokinetics of tideglusib in subjects with hepatic impairment compared to healthy subjects.

This study looks at a new medicine called tideglusib. We want to see how safe it is and how the body handles it in people with liver problems compared to healthy people. This helps us understand if the medicine works differently depending on liver health.

Safety Assessment of 10-Day Daily Bucco-Oral Administration of Transfer Factor in Healthy Adult Human Subjects

This study is looking at a new medicine called Transfer Factor to see if it's safe for healthy adults. It's an early-stage study to check for any side effects when people take it daily for 10 days.

A Single Dose, Fasting state, Crossover Replicate Bioequivalence Study of Naproxen 500 mg/Esomeprazole 20 mg, modified-release tablets (Antibiotice S.A.) vs. Vimovo® 500 mg/20 mg film-coated tablets (Grunenthal Gmbh)

This study compares a new naproxen and esomeprazole tablet to an existing one. It checks if they work the same way in healthy people. This helps make sure new medicines are just as good as older, approved ones.

The Critical Link Between Gut Microbiome Dysfunction, Cravings and Relapse: RECLAIM-GUT TRIAL

This study looks at how your gut's tiny living bugs might affect cravings and alcohol use. Researchers are testing special food supplements (prebiotics) designed just for you, to see if they can help improve your gut health and, in turn, your overall well-being. It's for healthy adults who drink alcohol moderately.

This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of BEAM-103 in Healthy Subjects

This study is testing a new medicine called BEAM-103 in healthy volunteers to see if it's safe. We'll also check how the body handles the medicine and how it affects blood. It's a first step to understand this potential new treatment.

A Single Dose, Fast state, Crossover Replicate Bioequivalence Study of NITROFURANTOIN 100 mg prolonged-release capsules (IASIS PHARMA) vs.FURABID® 100 mg prolonged-release capsules (Amdipharm Limited)

This study compares a new version of the antibiotic nitrofurantoin (IASIS PHARMA) with the existing Furabid® for treating bladder infections. It checks if both medicines release into the body in the same way, using healthy volunteers. This is a standard early check for new medications.

A randomized, balanced, two-treatment, two-sequence, single oral dose, two stage crossover adaptative bioequivalence study of Rifaximin 200 mg film-coated tablets (Antibiotice SA) vs. Normix® 200 mg, film- coated tablets (Alfasigma S.P.A) in healthy subjects under fed conditions

This study compares two versions of a 200mg rifaximin tablet to see if they work the same way in the body. It involves healthy adults taking a single dose of each tablet, with food, to ensure they're equally effective. It's an important step before a new medicine can be widely used.

A Single Dose, Fast State, Bioequivalence Study of CEFIXIMA ATB 400 mg Hard Capsules (Antibiotice S.A.) vs. CEFIXORAL® 400 mg Film Coated Tablets (A. Menarini Industrie Farmaceutiche Riunite s.r.l.)

Tramadol Administered Orally to Healthy Subjects for the Improvement of its Detection in Biological Matrices in the Context of Anti-Doping Control

Rivaroxaban sotorasib interaction study (the ROSIE-study)

A Single Dose, Fed state, Crossover Replicate Bioequivalence Study of NITROFURANTOIN 100 mg prolonged-release capsules (Iasis Pharma) vs. FURABID® 100 mg prolonged-release capsules (Amdipharm Limited)